Clinical Trial Update: A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Lutetium-177Lu BL-ARC001 in locally advanced or metastatic gastrointestinal cancers and other solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Solid Tumor

Drugs mentioned

• Lutetium-177Lu BL-ARC001 (BL-ARC001)

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Gastrointestinal Tumors, Solid Tumors | Phase 1 | Status: RECRUITING